Detection of cardiac sarcoidosis using cardiac markers and myocardial integrated backscatter
- 1 July 2005
- journal article
- research article
- Published by Elsevier in International Journal of Cardiology
- Vol. 102 (2) , 259-268
- https://doi.org/10.1016/j.ijcard.2004.05.028
Abstract
No abstract availableKeywords
This publication has 38 references indexed in Scilit:
- Determination of Successful Reperfusion After Thrombolysis for Acute Myocardial InfarctionCirculation, 2002
- Towards a blood test for heart failure: the potential use of circulating natriuretic peptidesBritish Journal of Clinical Pharmacology, 2000
- Myocardial integrated ultrasonic backscatter in patients with dilated cardiomyopathy: Prediction of response to β-blocker therapyAmerican Heart Journal, 2000
- Myocardial integrated ultrasonic backscatter in patients with dilated cardiomyopathy: Prediction of response to [beta ]-blocker therapyAmerican Heart Journal, 2000
- Biochemical detection of left-ventricular systolic dysfunctionThe Lancet, 1998
- Abnormal myocardial acoustic properties in diabetic patients and their correlation with the severity of diseaseJournal of the American College of Cardiology, 1992
- Two-dimensional echocardiographic findings in systemic sarcoidosisThe American Journal of Cardiology, 1989
- A relationship between ultrasonic integrated backscatter and myocardial contractile function.Journal of Clinical Investigation, 1985
- Echocardiographic evaluation of patients with systemic sarcoidosisAmerican Heart Journal, 1985
- The dependence of myocardial ultrasonic integrated backscatter on contractile performance.Circulation, 1985